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ABSTRACT
Cerebral blood reduction resulting in oligemic energy failure and metabolic insufficiency initiates gradual 
neurodegeneration and cognitive impairments. We investigated the neuroprotective effects of p-hydroxycinnamic acid 
(pHCA) on neurodegeneration in association with cognitive impairments in rats with chronic cerebral hypoperfusion 
(CCH). Forty male Sprague-Dawley rats were randomly divided into 4 groups: Sham-veh, 2VO-veh, 2VO-pHCA50 and 
2VO-pHCA100. We used modified 2-vessel occlusion (2VO) to induce CCH, and the 2 latter groups were given 50 mg/
kg and 100 mg/kg of pHCA after the 2VO operation, respectively, which continued for 3 weeks. The behavioral tests 
consisted of anxiety-like behavior tested in an elevated plus maze (EPM) and hippocampal-dependent spatial learning and 
flexibility tested in a Morris water maze (MWM). Brain oxidative status, infarction, vulnerable hippocampus and corpus 
callosum (CC) white matter degeneration were evaluated. The results showed that modified 2VO induced reversible short-
term anxiolytic-like behavior in the EPM (p < 0.05). Brain tissue analysis showed that modified 2VO induced gradual 
change to brain oxidative status (p > 0.05) with significance infarction, vulnerable hippocampal CA1, CA3, DG and 
CC degeneration (p < 0.05). These were found along with significant spatial learning and flexibility deficits (p < 0.05). 
Additionally, 100 mg/kg of pHCA significantly ameliorated the spatial learning and flexibility deficits, which coincided 
with the significant decreases of infarction volume, CA1, CA3 and CC degeneration (p < 0.05). We conclude that pHCA’s 
improving effects on spatial learning and flexibility deficits are neuroprotective against oligemic energy failure-induced 
vulnerable neuronal and white matter degeneration in CCH rats. 
Keywords: Bilateral common carotid artery occlusion; chronic cerebral hypoperfusion; learning flexibility; modified 
2VO; p-hydroxycinnamic acid; spatial learning; water maze
ABSTRAK
Pengurangan darah serebrum yang mengakibatkan kegagalan tenaga oligemik dan kekurangan metabolik merupakan 
permulaan neurodegenerasi saraf secara beransur-ansur dan merupakan masalah kognitif. Kami mengkaji kesan 
neuropelindung asid p-hidroksisinamik (pHCA) pada degenerasi saraf yang berkaitan dengan masalah kognitif pada 
tikus hypoperfusion cerebral kronik (CCH). Tikus Sprague-Dawley jantan empat puluh ekor secara rawak dibahagikan 
kepada 4 kelompok, iaitu Sham-veh, 2VO-veh, 2VO-pHCA50 dan 2VO-pHCA100. Kami menggunakan modul dua 
haluan kapal (2VO) untuk induksi CCH, dan kedua-dua kelompok terakhir diberikan pHCA 50 mg./kg. dan 100 mg./
kg. selepas 2VO beroperasi dan berterusan selama 3 minggu. Ujian tingkah laku terdiri daripada tingkah laku seperti 
kecemasan dalam lorongan keliru atas terbaik (EPM) dan pembelajaran reruang yang bergantung pada hipokampal dan 
kefleksibelan dalam lorongan keliru air Morris (MWM). Status oksidatif otak, otot, hipokampus dan korpus kalosum (CC) 
degenerasi bahan putih yang dinilai. Hasil menunjukkan bahawa 2VO diubah suai yang disebabkan oleh tingkah laku 
seperti anziolisis jangka pendek yang boleh diterbalikkan dalam EPM (p <0.05). Analisis tisu otak menunjukkan 2VO 
yang diubah suai secara beransur-ansur mengubah status oksidatif otak (p> 0.05) dengan infark bererti, hipokampal 
CA1, CA3, DG dan CC degenerasi yang terdedah (p <0.05). Ini ditemui bersama dengan pembelajaran reruang dan 
defisit kefleksibelan  (p <0.05). Kepentingan pHCA 100 mg./kg. meningkatkan pembelajaran reruang dan kekurangan 
kefleksibelan  bertepatan dengan penurunan bermakna kelantangan infarksi, CA1, CA3 dan CC degenerasi (p <0.05). 
Kami menyimpulkan bahawa pHCA meningkatkan kesan terhadap pembelajaran reruang dan defisit kefleksibelan 
melibatkan perlindungan saraf terhadap kegagalan tenaga oligemik yang disebabkan kemerosotan bahan neuron dan 
kemerosotan zat putih dalam tikus CCH.
Kata kunci: Asid p-hidroksisinamik; hipoperfusi serebrum kronik; kefleksibelan pembelajaran; lorongan keliru air; 
oklusi arteri karotid dua hala biasa; pembelajaran reruang;  2VO diubah suai
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INTRODUCTION
Many cases of neuronal dysfunction disease are caused 
by the reduction or cessation of cerebral blood flow (CBF), 
from both normal aging and neurodegenerative diseases 
(Du et al. 2016). Severely abrupt CBF reduction with or 
without reperfusion can lead to neuronal and white- matter 
damages associated with various disabilities (Erkinjuntti 
2008; Hou et al. 2002). Mild CBF reduction for a long 
time period or chronic cerebral hypoperfusion (CCH) 
can lead to delayed neuronal and white matter damages 
as well as disability (Bennett et al. 1998; De Jong et al. 
1999; de la Torre 2000). The pathomechanisms of CCH 
related to degenerations and disabilities can be provided 
through animal studies using two-vessel occlusion (2VO) 
to reproduce the CCH condition. This useful tool provides 
invaluable knowledge of CCH in terms of the metabolic 
changes and neuronal and white matter damages associated 
with disabilities (Farkas et al. 2007). The outcomes of CCH 
following disability come in many forms according to the 
specific brain area affected. The brain areas vulnerable to 
CBF reduction, such as the hippocampus, striatum, cortex 
and corpus callosum (CC), have a pivotal role in cognitive 
function (Teschendorf et al. 2008). Learning, memory and 
flexibility are the most affected forms of cognition when 
CBF is reduced, and they are easy to evaluate in animals by 
using mazes (Bennett et al. 1998; De Jong et al. 1999; Sarti 
et al. 2002). These forms of cognition mainly involve the 
hippocampal neural circuit and its connections with related 
brain structures (Broadbent et al. 2004; Eichenbaum et al. 
1999; Gerlai et al. 2002; Kesner 2000; Moser et al. 2009; 
Sasaki et al. 2015). Therefore, CCH-induced cognitive 
impairments coincide with the degree of hippocampal 
degeneration. Degeneration of the hippocampus and CC 
was promptly found 2 days after CCH. Such degeneration 
coincides with learning, memory and flexibility deficits, 
and the severity gradually increases with time (Otori et al. 
2003). CCH also induces psychological behaviors, and one 
of the most contradictory is anxiety-like behavior. Rats are 
less anxious when tested in an elevated T-maze (de Bortoli 
et al. 2005) but not less anxious when tested in an EPM (de 
Wilde et al. 2002). However, these results came from late 
testing after CCH onset. Therefore, the present study will 
confirm whether CCH induces anxiety-like behavior from 
early to late CCH onset. 
 It is well-known that CCH induces neurodegeneration 
via multiple pathomechanisms (Hou et al. 2002), with 
several pathways for energy-insufficient-induced 
excitotoxicity, neural inflammation and oxidative 
damage (Farkas et al. 2007). This is the reason why the 
interventions are in the form of multidrug therapy (Mehta 
et al. 2007). One substance may act against a variety of 
deleterious effects induced by CCH is p-hydroxycinnamic 
acid (pHCA). It is a hydroxyl-derivative organic compound 
of cinnamic acid that comes from natural sources, such 
as peanuts, barley grain, navy beans, tomatoes, carrots, 
basil, garlic, wine and vinegar (Pei et al. 2015). It exerts a 
beneficial effect in free oxygen radical scavengers (Tanyeli 
2018); improves mitochondrial function by decreasing 
apoptotic proteins; and increases nuclear respiratory 
factor (NRF-1), anxiolytic, anti-diabetic, anti-inflammatory, 
anti-cancer and anti-platelet aggregation (Abdel-Wahab 
2003; Amalan 2016; Guven et al. 2015). Recently, a 
neuroprotective effect against ischemic-reperfusion injury 
has been found (Sakamula & Thong-Asa 2018). Currently, 
the effects of pHCA on cognitive abilities associated with 
neurodegeneration have not been studied; therefore, the 
present study’s aim is to investigate the effects of pHCA 
against cognitive impairments in rats with CCH induced by 
2VO in relation to vulnerable neurodegeneration.
MATERIALS AND METHODS
CHEMICALS AND REAGENTS
The p-hydroxycinnamic acid and other biochemical 
analysis reagents used in this study were purchased 
from Chemical Express Co., Ltd. Merck Millipore 
(Samutprakarn, Thailand).
ANIMALS
Forty male Sprague-Dawley rats, aged 8 weeks old 
and weighing 250-300 g, were obtained from the 
National Laboratory Animal Centre, Mahidol University 
(Nakornpathom, Thailand). One rat was housed per cage, 
in a temperature-controlled room (25 ± 1ºC) on a 12 h light/
dark cycle, with food and water ad libitum. The procedure 
was performed under the guidelines of the Principles of 
Laboratory Animal Care and the Guide of the Care and Use 
of Laboratory Animals, approved by the National Institutes 
of Health. The protocol was approved by the Kasetsart 
University Institutional Animal Care and Use Committee 
(ID#ACKU61-SCI-012).
CHRONIC CEREBRAL HYPOPERFUSION
The rats were randomly divided into 4 groups: Sham-
veh, 2VO-veh, 2VO-pHCA50 and 2VO-pHCA100. Both 
common carotid artery occlusions were done as previously 
described (Cechetti et al. 2010). After fasting, all 2VO 
rats were anesthetized with an intraperitoneal injection 
of sodium pentobarbital (50 mg/kg) plus atropine sulfate 
(0.1 mg/kg). A neck ventral midline skin incision was 
made, and the right common carotid artery was carefully 
separated from the vagus nerve and permanently occluded 
with silk suture. The incision was stitched and treated 
with povidone-iodine solution along with a 5 mg/kg 
intramuscular injection of enrofloxacin. Unconscious rats 
were placed in a recovery chamber under a heat lamp 
and a blanket until full recovery. One week later, the left 
common carotid artery occlusion surgery was performed 
using the same procedures. Sham rats received the same 
surgical procedures without carotid artery occlusion. Oral 
administration via gavage feeding was started 24 h after the 
second operation. The 2VO-pHCA50 and 2VO-pHCA100 
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rats received 50 and 100 mg/kg of pHCA dissolved in 10% 
Tween 80 (as the vehicle), respectively, which continued 
for 3 weeks. The Sham-veh and 2VO-veh rats were 
received only vehicle. 
 As previous study used 100 mg/kg body weight of 
pHCA and proved the substance has neuroprotective effects 
against cerebral ischemia. In addition, the dose used in the 
study also based on preliminary studies with various dose 
(50, 75, 100 mg) that proved to be useful (Guven et al. 
2015).
SPATIAL LEARNING AND FLEXIBILITY EVALUATION
After one week of vehicle or pHCA administrations, the 
rats were evaluated for sensorimotor function and learning-
subordinated skills in the Morris water maze (MWM), 
which was defined as the cue test. The test consisted of 
a circular pool (150 cm in diameter) with a transparent 
platform that was exposed 2 cm over the water surface 
and located in the center area of the pool. The rats were 
released into the water to find the platform and given 4 
trials with 30 s inter-trial intervals. Each trial ended when 
the rat found and climbed onto the platform (120 s time 
limits for each trial). On the next day, spatial learning 
ability was tested for 5 consecutive days of acquisition 
sessions (ACQ) with the same protocol as the cue test, but 
the platform was submerged 2 cm below the water surface 
in the selected target quadrant. The following evaluation 
of learning flexibility was performed for 3 consecutive 
days of reversal sessions (REV). In this test, the hidden 
platform was switched to the opposite quadrant. All of the 
swimming trials were recorded and analyzed with Smart© 
version 3.0.04 (Planlab Harvard Apparatus). The data 
were represented as the escape time (s) to find the hidden 
platform of each session.
ANXIETY-LIKE BEHAVIOR TEST
The EPM test was carried out once a week (weeks 1, 2 and 3 
after CCH). The apparatus was a black, acrylic, plus-shaped 
maze elevated 50 cm above the ground, with 2 opposite 
closed arms and 2 opposite open arms, separated by a 
central junction (Plamondon & Khan 2005). Each rat was 
placed in the center of the maze facing an open arm and 
was allowed to freely explore the maze for 5 min. The time 
spent in and the number of entries into each type of arm 
were recorded, and anxiety-like behavior was indicated by 
the percentage of entries into the open arm.
DETERMINATION OF BRAIN OXIDATIVE STATUS
After the behavioral test, the rats were euthanized with a 
lethal dose of sodium pentobarbital (>60 mg/kg). Their 
brains were removed, and 10% w/v homogenate was 
prepared in cold phosphate buffer solution (PBS; 0.05 M, 
pH7.4); then, half of the homogenate was centrifuged at 
10,000 × g for 10 min at 4ºC. The homogenate and the 
supernatant were stored at -80ºC until assay.
 The biochemical parameters for assessing brain 
oxidative status, such as total protein, malondialdehyde 
(MDA), reduced glutathione (GSH), catalase (CAT) and 
superoxide dismutase (SOD) activities, were obtained by 
using the colorimetric method as previously described 
(Sakamula & Thong-Asa 2018).
BRAIN INFARCTION ANALYSIS
The brains were cut in a brain template into 2-mm-
thick serial coronal sections and stained with 2% of 
2,3,5-triphenyltetrazolium chloride (TTC) at 37°C for 10 
min and kept in 10% neutral buffer formalin for 24 h. Brain 
images were captured for infarction area analysis using 
NIH ImageJ and represented the whole brain percentage 
of the infarction area. 
NEURODEGENERATION ANALYSIS
The brains were processed, embedded in paraffin blocks 
and cut into 5-μm-thick slices using a rotary microtome. 
Brain sections were collected from the bregma at -2.80 to 
-3.80 mm of stereotaxic reference with an assurance area 
of the dorsal hippocampus (Paxinos & Watson 2006). 
Five sections from each rat were selected, beginning at 
the bregma at -3.14 mm with 125 μm intervals. The brain 
slides were deparaffinized and rehydrated with serial 
xylene and ethanol (EtOH; 100% and 95%, respectively), 
and then stained with 0.1% luxol fast blue (LFB) and left 
overnight in a hot air oven (56°C). The excessive dye was 
rinsed off with 95% EtOH, followed by distilled water. 
The slides were differentiated in 0.05% lithium carbonate 
solution and then in 70% EtOH, followed by distilled 
water. The sections were counterstained with 0.1% cresyl 
violet solution for 30 s, and excessive dye was rinsed off 
with distilled water. Then, the sections were dehydrated to 
serial EtOH (95 and 100%, respectively) and xylene and 
closed with cover slides.
 The areas of interest for LFB staining were the white 
matters in the CC. Three images were captured at 200× 
magnification using an Olympus Tg300 microscope. The 
density of myelinated fibers in the CC was then analyzed 
using NIH ImageJ and represented as the percentage of LFB 
area.
 For cresyl violet staining, the hippocampal areas 
of interest were the cornus ammonis (CA) 1 and 3 and 
the dentate gyrus (DG). Images were captured at 200× 
magnification using an Olympus Tg300 microscope. Three 
captured images of each hemisphere were used to count the 
number of viable and degenerating cells. Viable cells were 
characterized by light purple stains in the cytoplasm, with 
a visible nucleus and nucleolus. Degenerating cells were 
characterized by cell shrinkage, dark purple staining from 
the cresyl violet, the disappearance of the nucleolus, and 
the appearance of vacuoles around the cells (Thong-Asa 
& Tilokskulchai 2014). The data were represented as the 
percentage of degeneration in each area of interest. 
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STATISTICAL ANALYSIS
All data were expressed as mean ± standard error of the 
mean (SEM). The escape latency was analyzed by repeated-
measures ANOVA followed by Fisher’s post hoc test. The 
other variables were analyzed by one-way ANOVA followed 
by Fisher’s post hoc test. Statistical significance was 
defined as p < 0.05.
RESULTS AND DISCUSSION
None of the rats die after the operations, and they showed 
no signs of sensorimotor deficit in the mazes. The cue test 
results, as represented by swim speed (Table 1), showed 
no significant differences among the groups (p > 0.05). 
These results indicated that the operation and vessel 
occlusion did not influence visual and swimming ability 
in the MWM. Biochemical analysis of the brain tissue 
showed no differences in any of the assessed parameters 
(p > 0.05).
 Figure 1 shows significant impairment in learning 
ability during the ACQ and REV sessions in 2VO-veh rats 
when compared with Sham-veh rats (p = 0.0005 and 
0.0289, respectively). Rats treated with 50 mg/kg and 100 
mg/kg of pHCA show significant decrease in escape time 
in the ACQ session (p = 0.0456 and 0.0108, respectively). 
Only 100 mg/kg of pHCA showed a significant decrease 
in escape time in the REV session when compared to the 
2VO-veh rats (p = 0.0128). The results indicated that 2VO 
can induce both spatial learning and flexibility deficits 
and that only 100 mg/kg of pHCA can improve these 
cognitive deficits in the MWM. 
 Figure 2 shows the results of the anxiety-like behavior 
assessment in the EPM from the first to the third week with 
2VO. The results indicated that 2VO induced reversible 
anxiolytic-like behavior, as represented by the significantly 
increased percentage of open arm entry at the first and 
second weeks when compared to the Sham-veh rats (p 
= 0.0116 and 0.0406, respectively). The anxiolytic-like 
behavior was still presented from the first to the second 
week and disappeared in the third week. Rats treated 
with 50 mg/kg and 100 mg/kg of pHCA showed the same 
trend as with 2VO of inducing anxiolytic-like behavior 
when compare to Sham-veh rats (p = 0.0023 and 0.0286, 
respectively). That the anxiolytic-like behavior was 
induced solely by 2VO was confirmed by the insignificant 
relationship between 2VO with or without pHCA treatment. 
The whole brain infarction area in Figure 3 indicated that 
2VO-veh rats had significantly increased infarction areas. 
This was represented by the high percentage of infarction 
in the 2VO-veh rats when compared to the Sham-veh rats 
(p = 0.0461). Only the 2VO-pHCA100 group showed a 
significant decrease in infarction area when compared to 
the 2VO-veh group (p = 0.0103).
 The percentage of LFB density in CC was significantly 
reduced among the 2VO-veh rats compared to the Sham-
veh rats (p < 0.0001). Rats treated with 50 mg/kg and 100 
mg/kg of pHCA had significantly less LFB density reduction 
in CC when compared to the 2VO-veh rats (p < 0.0001 and 
p < 0.0001, respectively). This finding coincides with the 
reduction of rarefaction and degenerating oligodendrocytes 
shown in Figure 4. 
TABLE 1. Swimming ability and brain oxidative status
 Sham-veh 2VO-veh 2VO-pHCA50 2VO-pHCA100
Swim speed (cm/s)
Protein (mg/mL)
MDA (mM)
GSH (mM)
CAT (U/mL)
SOD (U/mL)
14.79±1.38
4.912±0.128
10.268±2.720
0.141±0.012
11.562±3.314
6.346±0.181
14.34±1.07
4.837±0.084
14.336±3.422 
0.422±0.011
13.389±4.612
7.125±1.187
12.95±0.76
4.784±0.067
13.314±0.688
0.411±0.014
18.996±7.424
7.688±0.354
12.38±0.76
4.633±0.123
11.449±2.583
0.417±0.009
22.453±4.425
7.351±1.716
*Indicate significant difference compare to Sham-veh. #Indicate significant 
difference compare to 2VO-veh
FIGURE 1. Cognitive abilities in acquisition (ACQ) and reversal 
(REV) learning sessions in the MWM 
*Indicate significant difference compare to Sham-veh
FIGURE 2. The percentage of open arm entry in EPM
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*Indicate significant difference compare to Sham-veh. #Indicate significant 
difference compare to 2VO-veh
FIGURE 4. The CC white matter with LFB staining. 
Black arrows indicate rarefaction area with                          
degenerating oligodendrocytes
*Indicate significant difference compare to Sham. #Indicate significant 
difference compare to 2VO-veh
FIGURE 5. Hippocampal CA1 neurons with cresyl         
violet staining
 The degeneration of vulnerable hippocampal neurons 
in the CA1, CA3 and DG regions was significantly induced 
by 2VO (p = 0.0005, 0.0001 and 0.0089, respectively) 
(Figures 5-7). Only 100 mg/kg of pHCA indicated 
significant reductions of CA1 and CA3 degeneration (p = 
0.0186 and 0.0006, respectively) (Figures 5-6). In CA1, 
though 100 mg/kg of pHCA significantly reduced neuronal 
degeneration, a significant difference from Sham-veh 
still be presented (p = 0.0230) (Figure 5). In the DG, 2VO 
rats treated with pHCA had no statistically significant 
differences from the Sham-veh or 2VO-veh rats (Figure 
7). 
 The present study demonstrates a beneficial effect of 
pHCA against CCH. We found that 100 mg/kg of pHCA 
was an effective dose for neuroprotection and amelioration 
of cognitive deficits. The induction of CCH by 2VO is 
widely used nowadays, with benefits for reproducing 
cognitive deficits associated with neurodegeneration 
(Farkas & Luiten 2001; Farkas et al. 2006, 2004a, 2004b). 
However, this model causes a high mortality rate and 
has benefits for only a short experimental period, when 
the simultaneous occlusion is performed. In 2010, the 
modified 2VO model was proposed with similar benefits 
for pathological induction along with a low mortality rate 
(Cechetti et al. 2010). When using the modified 2VO 
model, cognitive deficits are indicated from 28 days to 3 
months after operation (Cechetti et al. 2010; Li et al. 2015). 
The present study used the modified 2VO model and found 
*Indicate significant difference compare to Sham-veh. #Indicate significant 
difference compare to 2VO-veh
FIGURE 3. Brain sections with TTC staining. Black arrows 
indicate the infarction area represented 
by pale tissue color 
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that the deficits in spatial learning and learning flexibility 
were depicted 2-3 weeks after the CCH’s onset. Our results 
confirm early deficits since standard and modified 2VO 
were tested (Cechetti et al. 2010; Li et al. 2015; Liu et 
al. 2005). These cognitive deficits were found along with 
significance degeneration of vulnerable CA1, CA3, and 
DG neurons of the dorsal hippocampus and the CC, which 
provides additional confirmation of the susceptibility of 
these areas’ neuron and white matter to CCH. In addition, the 
EPM results of our anxiety-like behavioral test indicated that 
2VO induces reversible short-term anxiolytic-like behavior 
in rats. Unlike in a previous report (de Wilde et al. 2002), 
in which 2VO rats did not express anxiety-like behavior 
in EPM, this study test at the third week after 2VO onset. 
Anxiety-like behavior in the present study was tested at the 
first, second and third weeks after 2VO onset and we found 
CCH significance induce anxiolytic-like behavior in the first 
week, then it is disappeared at the second and third week in 
2VO-veh rats. This is a result of the modified 2VO, which 
reduced the persistence of CBF by about 30% and 20% at 
24 h to 28 days, respectively, and influenced the neuronal 
functions (Li et al. 2015). The present study’s infarction 
area evaluation found the affected brain areas, such as 
the cerebral cortex, striatum and hippocampus (Figure 3). 
These brain areas are responsible for cognitive function 
and other related brain functions such as sensory, motor 
and emotional functions. Anxiety is a part of emotional 
function in the limbic structures’ connectivity and can be 
affected by CBF alterations. Evidence showed that global 
cerebral ischemia can induce anxiolytic-like behavior in 
the first week (Yan et al. 2007). This is associated with 
alterations to the dopaminergic neurotransmitter system 
along with changes to anxiety-like behavior induced by 
ischemia (Winter et al. 2005). The temporary presence 
of anxiolytic-like behavior in the first week may involve 
this alteration. A significant increase in anxiolytic-like 
behavior among the pHCA-treated groups was found from 
the first to the second week, as compared to the Sham-veh 
rats. The first-week anxiety change may have been the 
combine effect of CCH with pHCA, while the second-week 
difference may have been solely the anxiolytic effect of 
pHCA as a receptor agonist on the gamma-aminobutyric 
acid (GABA) neurotransmitter circuitry (Scheepens et al. 
2014). The anxiolytic effect caused by CCH and pHCA was 
temporarily in the present study. Open arm avoidance may 
have been habituated over repeated trials for the Sham-veh 
rats, which may have caused a lack of differences in the 
third-week EPM test (Schrader et al. 2018). 
 The neuroprotective effects of pHCA in the present 
study were represented by the decreases to whole brain 
infarction and to hippocampal and CC degeneration in 
the pHCA-treated rats. The decrease of infarction area 
represented by the aerobic respiration marker, NADH, 
shows that 100 mg/kg of pHCA prevented the increase 
of pale tissue area. This involves an ameliorative effect 
of pHCA on energy failure from the increase in NRF-1 
and nuclear gene-encoding respiration protein (Guven 
et al. 2015), which maintains metabolism and help to 
*Indicates significant difference compare to Sham
 
FIGURE 7. Hippocampal DG neurons with 
cresyl violet staining
*Indicate significant difference compare to Sham. #Indicate significant difference 
compare to 2VO-veh
FIGURE 6. Hippocampal CA3 neurons with cresyl                   
violet staining
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protect from neurodegeneration and cognitive deficits. 
pHCA’s effect of preventing infarction area expansion also 
involves improved mitochondrial function by decreasing 
apoptotic proteins and the anti-inflammatory effects of 
pHCA (Abdel-Wahab 2003; Amalan 2016), which further 
contribute to neuroprotection against vulnerable neuronal 
and white matter degeneration.
 Spatial learning and flexibility deficits in the MWM 
were associated with CA1, CA3, DG and CC damage. In 
the CC, both 50 and 100 mg/kg of pHCA can prevent the 
decrease of LFB density, rarefaction and oligodendrocyte 
degenerations, but in vulnerable brain regions such as CA1 
and CA3, only 100 mg/kg was effective. Spatial learning 
deficits in the ACQ session were improved among rats 
treated with both 50 and 100 mg/kg of pHCA. Flexibility 
deficits in the REV session were improved only by 100 
mg/kg of pHCA. In considering pHCA’s effects on spatial 
learning improvements and CA1 and CA3 degeneration, 
spatial learning requires a minilab of hippocampal 
volume (Moser et al. 1995). Therefore, the significant 
degeneration of CA1 and CA3 did not coincide with the 
intact acquisition function. In reversal learning, only 100 
mg/kg of pHCA improved learning flexibility, whereas 
50 mg/kg of pHCA did not. In addition to pHCA’s effects 
against CA3 degeneration, 100 mg/kg was effective against 
histological and functional changes. This indicated more 
involvement of CA3 in reversal learning than CA1. In 
fact, both acquisition and reversal learning in the MWM 
are hippocampal-dependent cognitive types (Morris 1984; 
Moser & Moser 1998; Wolfer et al. 1998; Russig et al. 
2003), and alterations to the hippocampus produce greater 
effects on reversal learning than on initial spatial learning 
due to the differences in the neural circuits for learning 
and flexibility (Pouzet et al. 1999). The CA1 hippocampal 
place cells acquire spatial location, with entorhinal grid 
cells also participating (O’Keefe 1993; O’Keefe & Conway 
1978; O’Keefe & Dostrovsky 1971). In reversal learning, 
the neural basis involves the cortical regions, orbitofrontal 
cortex (OFC), striatal, amygdala (Izquierdo et al. 2016) 
and hippocampus (Vila-Ballo et al. 2017). It has been 
shown that CA1 and CA3 cells firing respond differently 
to familiar versus changed environments (Bahar et al. 
2011), and the within- hippocampal circuit (CA1, 3 and 
DG) contributes differently to distinct aspects of spatial 
cognition. The within circuit of reversal learning needs 
more cooperation between CA3 and other local areas 
(Kesner 2007) together with the frontocorticostriatal 
circuitry (Izquierdo & Jentsch 2012). The present study 
found that only 100 mg/kg of pHCA can prevent CA3 
degeneration, associated with significant improvement to 
flexibility deficits in reversal learning. Improving pHCA’s 
effects on cognitive function involves enhancing CA1’s 
long-term potentiation (LTP). The synaptic strengthening 
is modified by the N-methyl-D-aspartic acid (NMDA) 
receptor channel and modulations to the central cholinergic 
neurotransmitter system (Kim et al. 2017).
 Regarding the oxidative stress induced by CCH in 
neurodegeneration, oligemic energy failure leading to 
metabolic insufficiency is initiate a variety of deteriorations 
(Farkas et al. 2007). Brain oxidative stress induction was 
not clear in the early phase of CCH in the present study, 
and biochemical parameters such as protein level, MDA, 
CAT, SOD and GSH showed no differences. A previous study 
indicated that changes can be found in the whole brain at 8 
weeks after 2VO, which suggested that the changes in brain 
oxidative status are gradual in the 2VO model (Saxena et 
al. 2015). Therefore, the present study cannot claim the 
effects of pHCA against brain oxidative stress. However, 
some evidence implied pHCA’s benefits against oxidative 
stress in severely ischemic conditions (Guven et al. 2015; 
Sakamula & Thong-Asa 2018).
CONCLUSION
We conclude that pHCA’s positive effects on spatial 
learning and flexibility deficits involve neuroprotection 
against oligemic energy failure, which induces vulnerable 
neuronal and white matter degeneration in CCH rats.
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